2021, Number 01
<< Back Next >>
Ginecol Obstet Mex 2021; 89 (01)
A 10-years cardiovascular disease risk using central obesity in aging female
Zacarías-Flores M, González-Herrera IV, Sánchez-Rodríguez MA
Language: Spanish
References: 30
Page: 14-23
PDF size: 266.62 Kb.
ABSTRACT
Objective: To determine if central adiposity predicts 10-year cardiovascular risk and
changes across the female reproductive aging.
Materials and Methods: A cross-sectional study was carried out in women recruited
from march to august of 2019 in the Research Unit on Gerontology, Facultad
de Estudios Superiores Zaragoza, UNAM. Clinically healthy women aged 40 to 69
years old, with diabetes mellitus and/or arterial hypertension, and no other diseases,
without hormonal or antioxidant therapy 6 months before the beginning of the study
were included. The women were separated into three groups according to the STRAW
criteria. The main variables were central obesity with anthropometric measurements
and Framingham 10-year cardiovascular disease risk assessment. Statistical analysis
included descriptive measures; and as inferential test: Student’s t test, one-way ANOVA,
χ
2, Pearson’s correlation and odds ratio.
Results: 558 women were recruited: 206 pre-menopausal, 224 early post-menopausal,
and 128 late post-menopausal. The prevalence of overweight/obesity was high in the
three groups and 10-year cardiovascular disease risk increase with the reproductive
aging. When stratified by menopausal status we found a correlation between cardiovascular
risk and waist to height index (r = 0.434, p ‹ 0.0001) and waist circumference
(r = 0.428, p ‹ 0.0001), being the waist to height index a risk factor to cardiovascular
disease (RM = 3.26, IC95%: 1.73-6.12, p ‹ 0.0001), only in premenopausal women,
while in postmenopausal women there is no relation.
Conclusión: The central obesity obtained by the waist to height index is a 10-year
cardiovascular disease risk factor in premenopausal, but not in postmenopausal women.
REFERENCES
Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocrin Rev. 2009; 30: 465-493. https://doi.org/10.1210/er.2009-0006.
Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric. 2007; 10: 19-24. https://doi.org/10.1080/13697130601114917.
Savonitto S, Ferri LA, Colombo D. Perimenopause vasomotor symptoms, coronary atherosclerosis and risk of myocardial infarction during menopause: the cardiologist’s perspective. Menopause Rev 2018; 17: 53-56. doi: 10.5114/pm.2018.77301.
North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012; 110: 1097-1108. https://doi.org/10.1161/CIRCRESAHA.111.246876.
Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012; 8 (1): 143-164. doi:10.1016/j. hfc.2011.08.011.
Dasgupta S, Salman M, Lokesh S, Xaviour D, Saheb SY, Prasad BV, Sarkar B. Menopause versus aging: The predictor of obesity and metabolic aberrations among menopausal women of Karnataka, South India. J Midlife Health. 2012; 3 (1): 24-30. doi: 10.4103/0976-7800.98814.
Elffers TW, de Mutsert R, Lamb HJ, de Roos A, Willems van Dijk K, Rosendaal FR, et al. Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women. PLoS ONE 2017; 12 (9): e0185403. https://doi.org/10.1371/journal.pone.0185403.
Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences, in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Heart Circ Physiol. 2018; 315 (6): H1569- H1588. doi: 10.1152/ajpheart.00396.2018.
Hernández-Rodríguez J, Duchi-Jimbo PN. Índice cintura/ talla y su utilidad para detectar riesgo cardiovascular y metabólico. Rev Cubana Endocrinol 2015; 26: 66-76.
Hanley C, Matthews KA, Brooks MM, Janssen I, Budoff MJ, Sekikawa A, et al. Cardiovascular fat in women at midlife: effects of race, overall adiposity, and central adiposity. The SWAN Cardiovascular Fat Study. Menopause. 2018; 25 (1): 38-45. doi:10.1097/GME.0000000000000945.
Corrêa MM, Thumé E, Araújo De Oliveira ER, Tomasi E. Performance of the waist-to-height ratio in identifying obesity and predicting non-communicable diseases in the elderly population: A systematic literature review. Arch Gerontol Geriatr. 2016; 65: 174-182. doi.10.1016/j. archger.2016.03.021.
D’Agostino RB Sr, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Global Heart. 2013; 8: 11-23. doi. 10.1016/j. gheart.2013.01.001.
Goh LGH, Welborn TA, Dhaliwal SS. Independent external validation of cardiovascular disease mortality in women utilizing Framingham and SCORE risk models: a mortality follow-up study. BMC Women’s Health 2014; 14: 118. doi. 10.1186/1472-6874-14-118.
Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. Menopause. 2001; 8: 402-407.
Diario Oficial de la Federación. NORMA Oficial Mexicana NOM-008-SSA3-2010, Para el tratamiento integral del sobrepeso y la obesidad. México, 4 agosto 2010.
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014; 63 (25 Pt B): 2985-3023. doi. 10.1016/j.jacc.2013.11.004.
Colpani V, Oppermann K, Spritzer PM. Causes of death and associated risk factors among climacteric women from Southern Brazil: a population-based study. BMC Public Health 2014; 14: 194. doi. 10.1186/1471-2458-14-194.
Instituto Nacional de Estadística y Geografía. Principales causas de mortalidad por residencia habitual, grupos de edad y sexo del fallecido. Disponible en: https://www. inegi.org.mx/sistemas/olap/registros/vitales/mortalidad/ tabulados/ConsultaMortalidad.asp.
Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart 2015; 101: 1182-1189. doi.10.1136/ heartjnl-2015-307516.
Rojas R, Aguilar-Salinas CA, Gómez-Pérez FJ, Valles V, Franco A, Olaiz G, et al. Applicability of the National Cholesterol Education Program III (NCEP-III) guidelines for treatment of dyslipidemia in a non-Caucasian population: a Mexican nation-wide survey. Rev Invest Clin. 2005; 57 (1): 28-37.
Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837- 1847. doi.10.1161/01.cir.97.18.1837.
Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, et al. Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the Framingham risk score: the suita study. J Atheroscler Thromb. 2014; 21 (8): 784-798. doi. 10.5551/jat.19356.
Chia YC, Gray SYW, Ching SM, Lim HM, Chinna K. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. BMJ Open 2015; 5: e007324. doi.10.1136/bmjopen- 2014-007324.
Saidi O, Malouche D, O’Flaherty M, Ben Mansour N, Skhiri HA, Ben Romdhane H, Bezdah L. Assessment of cardiovascular risk in Tunisia: applying the Framingham risk score to national survey data. BMJ Open 2016; 6: e009195. http:// dx.doi.org/10.1136/bmjopen-2015-009195.
Abulmeaty MMA, Almajwal AM, Almadani NK, Aldosari MS, Alnajim AA, Ali SB, et al. Anthropometric and central obesity indices as predictors of long-term cardiometabolic risk among Saudi young and middle-aged men and women. Saudi Med J. 2017; 38 (4): 372-380. doi.10.15537/ smj.2017.4.18758.
Choi S, Kim K, Kim SM, Lee G, Jeong S-M, Park SY, et al. Association of obesity or weight change with coronary heart disease among young adults in South Korea. JAMA Intern Med. 2018; 178 (8): 1060-1068. doi.10.1001/jamainternmed. 2018.2310.
Kong KA, Park J, Hong S-h, Hong YS, Sung Y-A, Lee H Associations between body mass index and mortality or cardiovascular events in a general Korean population. PLoS ONE. 2017;12(9): e0185024. https://doi.org/10.1371/ journal.pone.0185024.
Luengo-Pérez LM, Urbano-Gálvez JM, Pérez-Miranda M. Validación de índices antropométricos alternativos como marcadores del riesgo cardiovascular. Endocrinol Nutr. 2009;56(9):439-446. https://doi.org/10.1016/S1575- 0922(09)72964-X.
Torresani ME, Oliva ML, Rossi ML, Echevarría C, Maffei L. Riesgo cardiovascular según el índice cintura/talla en mujeres adultas. Actualiz Nutr. 2014; 15 (1): 3-9.
Peppa M, Koliaki C, Hadjidakis DI, Garoflos E, Papaefstathiou A, Katsilambros N, et al. Regional fat distribution and cardiometabolic risk in healthy postmenopausal women. Eur J Intern Med. 2013; 24: 824-831. https://doi. org/10.1016/j.ejim.2013.07.001.